Fecal incontinence is defined as the involuntary loss of liquid or solid stool, whereas anal incontinence, commonly termed “accidental bowel leakage” (ABL), also includes the loss of flatus. The prevalence of ABL in large ambulatory populations ranges from 1% to over 20%. The biggest identified risk factors include diarrhea and advancing age.
The anal sphincter complex is made up of the internal (IAS) and external anal sphincters (EAS) that provide both resting and increased voluntary tone of the anal canal. The IAS is a condensation of the circular smooth muscle of the bowel wall that provides 75% of the resting tone and serves as the primary barrier against stool leakage. The EAS is made up of striated muscle and is innervated by the pudendal nerve. The external sphincter and puborectalis muscle provide the voluntary components of fecal continence.
Fecal incontinence may be caused by anatomical abnormalities including effects on the sphincter, puborectalis, or nerve injury, including the pudendal nerve. Functional abnormities such as anorectal sensation, stool characteristics including consistency, and medications may affect continence. Anal sphincter weakness may be atraumatic (such as neurologic disorders) or traumatic, including obstetric injury and pudendal nerve injury. Additionally, rectal urgency is a significant risk factor for fecal incontinence in women. The greatest risk factor for anal sphincter injury is operative vaginal delivery (forceps higher risk than vacuum), followed by primiparity, midline episiotomy, occiput posterior head position, macrosomia, and prolonged second stage.
Evaluation should include a comprehensive medical, surgical, and obstetric history, to include distinguishing true incontinence form urgency, medications, and signs/symptoms of neurologic disease. Questions should include the onset and duration of symptoms, the quality and consistency of the stool that is successfully stored versus leaked, and the patient's bowel habit history. Physical examination includes evaluation of the perianal area and digital rectal examination, as well as assessment of perineal sensation and evaluation of pelvic support. Digital exam may evaluate for sphincter tone and weakness but may not always provide accurate assessment. Potentially helpful diagnostic tests include endoanal ultrasonography, and anal manometry. Ultrasound effectively evaluates anal sphincter anatomy, while anal manometry provides information about rectal sensation and compliance. Although these tests can be useful in the management of complex patients they are not recommended in the initial management of patients with fecal incontinence. Colonoscopy should be recommended in these patients especially when accompanied by other symptoms such as abdominal pain, rectal bleeding or anemia.
Management includes dietary manipulation and bowel schedules, as well as medications to decrease colonic motility (Loperamide, Immodium, Cholestyramine), stool bulking agents, biofeedback, a vaginal insert with a balloon that obstructs the rectum, sphincter bulking agents, sacral neuromodulation and surgery. Maintaining normal stool consistency and frequency is imperative, regardless of the integrity of the anal sphincter complex. Failure of initial management of these patients should trigger referal to a specialist with experience in managing these disorders.
Sphincteroplasty is reserved for women with evidence of an anatomic defect who do not respond to initial management, Short-term benefit is achieved in over 85% of patients; however, long-term success rates only approximate 50%.
American College of Obstetricians and Gynecologists, ACOG Practice Bulletin No. 210: Fecal Incontinence. Obstet Gynecol. 2019 Apr;133(4):e260-e273. doi: 10.1097/AOG.0000000000003187.
Wald A, Bharucha AE, Cosman BC, Whitehead WE, American College of Gastroenterology, ACG clinical guideline: management of benign anorectal disorders., Am J Gastroenterol. 2014 Aug;109(8):1141-57; (Quiz) 1058. doi: 10.1038/ajg.2014.190. Epub 2014 Jul 15.
Wald A. Diagnosis and Management of Fecal Incontinence. Curr Gastroenterol Rep. 2018 Mar 26;20(3):9. doi: 10.1007/s11894-018-0614-0.
Initial Approval: May 2015, Reviewed November 2016, Revised May 2018, Revised November 2019
********** Notice Regarding Use ************
The Foundation for Exxcellence in Women’s Health, Inc (“Foundation”) is committed to accuracy and will review and validate all Pearls on an ongoing basis to reflect current practice.
This document is designed to aid practitioners in providing appropriate obstetric and gynecologic care. Recommendations are derived from major society guidelines and high quality evidence when available, supplemented by the opinion of the author and editorial board when necessary. It should not be construed as dictating an exclusive course of treatment or procedure to be followed.
Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. The Foundation reviews the articles regularly; however, its publications may not reflect the most recent evidence. While we make every effort to present accurate and reliable information, this publication is provided “as is” without any warranty of accuracy, reliability, or otherwise, either express or implied. The Foundation does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither the Foundation, the ABOG, SASGOG nor their respective officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented.
Copyright 2019 The Foundation for Exxcellence in Women's Health, Inc. All rights reserved. No re-print, duplication or posting allowed without prior written consent.Back to Search Results